Avenio.ai has appointed Dr. Megha Vasavada as VP of Product Management to lead product strategy for AvenioGPT, bringing over a decade of experience in clinical research to transform insight generation and decision-making across the clinical trial lifecycle.

Avenio Corp launched AvenioGPT, an AI platform for life sciences and clinical research designed to reduce friction, enhance research velocity, and deliver actionable insight across BioPharma workflows, with early demand from 24 BioPharma entities and academic research institutes.

Avenio joins NVIDIA Inception Program to scale Gen AI powered drug development process to revolutionize BioPharma research, reasoning, and coordination. The program provides access to NVIDIA's cutting-edge AI computing platform and resources to accelerate enterprise-grade BioPharma solutions.